Neurofenac capsules
Recall
|
Medicines
|
28/11/2017
The marketing authorization holder informed its supplied customers in a letter dated 27.11.2017 that the stability test did not comply with the test for gastric juice resistance. The potential impact on patient safety is assessed as low. All other batches available in Austria are not affected by this recall.
| Name of the medicinal product | Neurofenac-Kapseln |
|---|---|
| Marketing authorisation number(s) | 1-18584 |
| Marketing authorisation holder | Merck Gesellschaft mbH |
| Batch number(s) | 025817A, 025817B, 025817C, 025817D und 025817E |
| Classification of the recall | II |
| BASG reference number | INS-640.001-2347 |
Further inquiry note
Page last modified:
12/07/2022